The capsules segment by product type is estimated to lead the market growth during the forecast period.

According to a new market research study of “North America Microbial Air Sampler Market Forecast to 2028 - COVID-19 Impact and Regional Analysis by Product, Collection Technique, Distribution Channel, End User and Country.” The North America microbial air sampler market is expected to reach US$ 160.42 million in 2028 from US$ 89.46 million in 2021; it is estimated to grow at a CAGR of 8.7% from 2021 to 2028. The report highlights trends prevailing in the North America microbial air sampler market and the factors driving market along with those that act as hindrances. 

Nearly 50 million COVID-19 cases have already been reported worldwide, with over a million deaths. SARS-CoV-2 genomic RNA has been detected in airborne material collected by air samplers positioned distal to COVID-19 patients. It has also been reported that microbial air sampling has a vital role in detecting etiologic agents. As the COVID-19 pandemic evolves, technological applications and initiatives are emerging in an attempt to control the spread of the disease. Anderson bioaerosol sampler was developed by the National Institute for Occupational Safety and Health (NIOSH) for sampling and identification of culturable microorganisms in workplaces. A field guide for detecting biological agents in environments has also been recommended by the American Industrial Hygiene Association (AIHA). Even if people come back to normalcy, there will remain a risk of infection. The safe reopening of public spaces such as schools and restaurants will require effective environmental air monitoring technologies. Such methods will help in understanding and preventing infections. To combat disease spread, early warning, detection, or identification of air contamination is important. All the aforementioned factors are, therefore, driving the microbial air samplers market.

The North America microbial air sampler market, based on product is segmented into capsules, injection, and tablets. The North America microbial air sampler market based on the application was segmented into angina, hypertension, and others. Geographically, the North America microbial air sampler market can be sub-segmented into U.S., Mexico and Canada.

Aerosol Devices Inc., Spectrex Corp., Cantium Scientific Limited, MERCK KGa and bioMerieux SA are among the leading companies operating in the North America microbial air sampler market.